Wegovy for sale | Buy Wegovy online
What is Wegovy (semaglutide) for?
Wegovy (semaglutide) is a medicine prescribed for chronic weight management. It’s intended for use in:
- Adult patients with BMI >30 kg/m2 (obese);
- Adult patients with BMI > 27 kg/m2 (overweight) and at least one weight-related comorbid condition, such as hypertension, type 2 diabetes, or dyslipidemia;
- Pediatric patients (12+) with BMI at the 95th percentile or greater for age and sex (obese) [1].
Wegovy (semaglutide) is available as an injection, in pre-filled single-dose pens that deliver doses of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg [1].
How does Wegovy (semaglutide) work?
Wegovy’s active substance, semaglutide, is a GLP-1 receptor antagonist. It mimics the activity of GLP-1, a natural hormone in the body. Semaglutide appears to regulate appetite by increasing feelings of fullness. It reduces hunger and cravings, and, consequently, food intake [3].
Where has Wegovy (semaglutide) been approved?
Wegovy (semaglutide) is approved in the USA, EU, UK, Japan, and Canada [2,3,4,5,6].
References:
- HIGHLIGHTS OF PRESCRIBING INFORMATION, Accessdata.fda.gov, . Accessed 20 November 2023.
- FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. FDA, 4 June 2021, Accessed 20 November 2023.
- Wegovy | European Medicines Agency, European Medicines Agency, Accessed 20 November 2023.
- New Drugs Approved in FY 2022. PMDA, 27 March 2023, Accessed 20 November 2023.
- Drug product database, Health Canada, Accessed 20 November 2023.
- Accessing Wegovy for weight loss: Everything you need to know – Department of Health and Social Care Media Centre. Department of Health and Social Care Media Centre, 4 September 2023.
Reviews
There are no reviews yet.